Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$346K Sell
25,594
-206
-0.8% -$2.88K ﹤0.01% 730
2025
Q4
$321K Buy
25,800
+12,351
+92% +$133K ﹤0.01% 688
2025
Q3
$133K Hold
13,449
﹤0.01% 760
2025
Q2
$120K Sell
13,449
-23,255
-63% -$197K ﹤0.01% 555
2025
Q1
$320K Buy
36,704
+15,657
+74% +$164K 0.01% 438
2024
Q4
$262K Hold
21,047
﹤0.01% 478
2024
Q3
$244K Buy
21,047
+6,230
+42% +$71.9K 0.01% 429
2024
Q2
$158K Sell
14,817
-18,688
-56% -$206K ﹤0.01% 534
2024
Q1
$400K Sell
33,505
-7,928
-19% -$95.5K 0.01% 286
2023
Q4
$449K Sell
41,433
-43,406
-51% -$416K 0.02% 324
2023
Q3
$837K Buy
84,839
+903
+1% +$9.4K 0.12% 83
2023
Q2
$838K Buy
83,936
+60,753
+262% +$580K 0.15% 97
2023
Q1
$223K Buy
23,183
+6,344
+38% +$70.4K 0.03% 225
2022
Q4
$187K Buy
+16,839
New +$176K 0.03% 236

Other funds holding VTRS

Marex Group's VTRS Position: Q1 2026 in Review

Marex Group reduced its Viatris (VTRS) stake by 0.8% in Q1 2026, selling an estimated $2.88K and leaving 25,594 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #730.

Marex Group first reported a position in VTRS in Q4 2022 and has held it in 14 quarters since. The position peaked at $838K in Q2 2023. 1,019 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.

  • Marex Group held 25,594 shares of Viatris worth $346K as of Q1 2026.
  • Marex Group sold 206 Viatris shares in Q1 2026, an estimated $2.88K.
  • Viatris made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #730 holding.
  • Marex Group first reported a position in Viatris in Q4 2022 and has held it in 14 quarters since.
  • Marex Group's Viatris position peaked at $838K in Q2 2023.
  • 1,019 funds tracked by Wall St. Rank held Viatris as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.